Carbapenemase OXA-423: A Novel OXA-23 Variant in Acinetobacter baumannii

References

• Abdi SN, Ghotaslou R, Ganbarov K, et al. Acinetobacter baumannii efflux pumps and antibiotic resistance. Infect Drug Resist. 2020;13:423–434. doi:10.2147/IDR.S22808932104014
   PubMed Web of Science ®Google Scholar
• Vivas R, Barbosa AAT, Dolabela SS, Jain S. Multidrug-resistant bacteria and alternative methods to control them: an overview. Microb Drug Resist. 2019;25(6):890–908. doi:10.1089/mdr.2018.031930811275
   PubMed Web of Science ®Google Scholar
• Tacconelli E, Carrara E, Savoldi A; for WHO Pathogens Priority List Working Group. Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis. Lancet Infect Dis. 2018;18(3):318–327. doi:10.1016/S1473-3099(17)30753-329276051
   PubMed Web of Science ®Google Scholar
• Ramirez MS, Bonomo RA, Tolmasky ME. Carbapenemases: transforming Acinetobacter baumannii into a yet more dangerous menace. Biomolecules. 2020;10(5):720. doi:10.3390/biom10050720
   PubMed Web of Science ®Google Scholar
• Hamidian M, Nigro SJ. Emergence, molecular mechanisms and global spread of carbapenem-resistant Acinetobacter baumannii. Microb Genom. 2019;5(10):e000306.
   PubMed Web of Science ®Google Scholar
• Santillana E, Beceiro A, Bou G, Romero A. Crystal structure of the carbapenemase OXA-24 reveals insights into the mechanism of carbapenem hydrolysis. Proc Natl Acad Sci U S A. 2007;104(13):5354–5359. doi:10.1073/pnas.060755710417374723
   PubMed Web of Science ®Google Scholar
• Toth M, Smith CA, Antunes NT, Stewart NK, Maltz L, Vakulenko SB. The role of conserved surface hydrophobic residues in the carbapenemase activity of the class D β-lactamases. Acta Crystallogr D Struct Biol. 2017;73(8):692–701. doi:10.1107/S205979831700867128777084
   PubMedGoogle Scholar
• Gundi VAKB, Dijkshoorn L, Burignat S, Raoult D, La Scola B. Validation of partial rpoB gene sequence analysis for the identification of clinically important and emerging Acinetobacter species. Microbiology. 2009;155(7):2333–2341. doi:10.1099/mic.0.026054-019389786
   PubMed Web of Science ®Google Scholar
• Diancourt L, Passet V, Nemec A, Dijkshoorn L, Brisse S. The population structure of Acinetobacter baumannii: expanding multiresistant clones from an ancestral susceptible genetic pool. PLoS One. 2010;5(4):e10034. doi:10.1371/journal.pone.001003420383326
   PubMed Web of Science ®Google Scholar
• Clinical and Laboratory Standards Institute (CLSI). Performance Standards for Antimicrobial Susceptibility Testing: Twenty-Ninth Informational Supplement M100-S29. Wayne, PA, USA: Clinical and Laboratory Standards Institute (CLSI); 2019.
   Google Scholar
• Bramucci E, Paiardini A, Bossa F, Pascarella S. PyMod: sequence similarity searches, multiple sequence-structure alignments, and homology modeling within PyMOL. BMC Bioinform. 2012;13(Suppl 4):S2. doi:10.1186/1471-2105-13-S4-S2
   Web of Science ®Google Scholar
• Couture F, Lachapelle J, Levesque RC. Phylogeny of LCR-1 and OXA-5 with class A and class D β-lactamases. Mol Microbiol. 1992;6(12):1693–1705. doi:10.1111/j.1365-2958.1992.tb00894.x1495394
   PubMed Web of Science ®Google Scholar
• Wong MH, Chan BK, Chan EW, Chen S. Over-expression of ISAba1-linked intrinsic and exogenously acquired OXA type carbapenem-hydrolyzing-class D-ß-lactamase-encoding genes is key mechanism underlying carbapenem resistance in Acinetobacter baumannii. Front Microbiol. 2019;10:2809. doi:10.3389/fmicb.2019.0280931866977
   PubMed Web of Science ®Google Scholar
• Lin YC, Hsia KC, Chen YC, et al. Genetic basis of multidrug resistance in Acinetobacter clinical isolates in Taiwan. Antimicrob Agents Chemother. 2010;54(5):2078–2084. doi:10.1128/AAC.01398-0920194701
   PubMed Web of Science ®Google Scholar
• Harper TM, June CM, Taracila MA, Bonomo RA, Powers RA, Leonard DA. Multiple substitutions lead to increased loop flexibility and expanded specificity in Acinetobacter baumannii carbapenemase OXA-239. Biochem J. 2018;475(1):273–288. doi:10.1042/BCJ2017070229229762
   PubMed Web of Science ®Google Scholar
• Afzal-Shah M, Woodford N, Livermore DM. Characterization of OXA-25, OXA-26, and OXA-27, molecular class D β-lactamases associated with carbapenem resistance in clinical isolates of Acinetobacter baumannii. Antimicrob Agents Chemother. 2001;45(2):583–588. doi:10.1128/AAC.45.2.583-588.200111158758
   PubMed Web of Science ®Google Scholar
• Tamayo-Legorreta EM, Garza-Ramos U, Barrios-Camacho H, et al. Identification of OXA-23 carbapenemases: novel variant OXA-239 in Acinetobacter baumannii ST758 clinical isolates in Mexico. New Microbes New Infect. 2014;2(6):173–174. doi:10.1002/nmi2.6025566396
   PubMedGoogle Scholar
• Graña-Miraglia L, Evans BA, López-Jácome LE, et al. Origin of OXA-23 variant OXA-239 from a recently emerged lineage of Acinetobacter baumannii international clone V. mSphere. 2020;5(1):e00801–19. doi:10.1128/mSphere.00801-1931915222
   PubMed Web of Science ®Google Scholar
• Kaitany KC, Klinger NV, June CM, et al. Structures of the class D carbapenemases OXA-23 and OXA-146: mechanistic basis of activity against carbapenems, extended-spectrum cephalosporins, and aztreonam. Antimicrob Agents Chemother. 2013;57(10):4848–4855. doi:10.1128/AAC.00762-1323877677
   PubMed Web of Science ®Google Scholar
• Poirel L, Figueiredo S, Cattoir V, Carattoli A, Nordmann P. Acinetobacter radioresistens as a silent source of carbapenem resistance for Acinetobacter spp. Antimicrob Agents Chemother. 2008;52(4):1252–1256. doi:10.1128/AAC.01304-0718195058
   PubMed Web of Science ®Google Scholar
• Gaiarsa S, Batisti Biffignandi G, Esposito EP, et al. Comparative analysis of the two Acinetobacter baumannii Multilocus Sequence Typing (MLST) schemes. Front Microbiol. 2019;10:930. doi:10.3389/fmicb.2019.0093031130931
   PubMed Web of Science ®Google Scholar